Catalysts for Long Grove Pharmaceuticals LLC
6 tracked
Mar 17, 2026
approval
AK-FLUOR 25% (FLUORESCEIN SODIUM) — FDA approval
Long Grove Pharmaceuticals LLC
→
Feb 26, 2026
approval
DALBAVANCIN HYDROCHLORIDE — FDA approval
Long Grove Pharmaceuticals LLC
→
Feb 2, 2026
approval
ESTRADIOL — FDA approval
Long Grove Pharmaceuticals LLC
→
Feb 28, 2025
approval
AK-FLUOR 25% (FLUORESCEIN SODIUM) — FDA approval
Long Grove Pharmaceuticals LLC
→
Jul 20, 2015
approval
AK-FLUOR 25% (FLUORESCEIN SODIUM) — FDA approval
Long Grove Pharmaceuticals LLC
→
Aug 8, 2008
approval
AK-FLUOR 25% (FLUORESCEIN SODIUM) — FDA approval
Long Grove Pharmaceuticals LLC
→